Feng-Yu Hu
Overview
Explore the profile of Feng-Yu Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng J, Ling Y, Jiang L, Mootsikapun P, Lu H, Chayakulkeeree M, et al.
Virol J
. 2023 Nov;
20(1):277.
PMID: 38017515
Background: In a randomized trial, Lianhuaqingwen (LHQW) capsule was effective for accelerating symptom recovery among patients with coronavirus disease 2019 (COVID-19). However, the lack of blinding and limited sample sizes...
2.
Guo P, He H, Chen X, Chen J, Chen X, Lan Y, et al.
Front Pharmacol
. 2021 Apr;
11:569766.
PMID: 33841131
Dual therapy with lopinavir/ritonavir (LPV/r) plus lamivudine (3TC) has been demonstrated to be non-inferior to the triple drug regimen including LPV/r plus two nucleoside reverse transcriptase inhibitors (NRTIs) in 48-week...
3.
Nie Y, Lan Y, Deng X, Li L, Cai W, Li F, et al.
Infect Genet Evol
. 2020 Aug;
84:104480.
PMID: 32736042
Background: Previous studies have reported that platelet count is associated with the progression of liver disease caused by hepatitis B virus (HBV), but there have been no reports on whether...
4.
Nie Y, Deng X, Lan Y, Li F, Hu F
Infect Drug Resist
. 2020 Jul;
13:1643-1649.
PMID: 32606815
Background: Combined HIV infection can accelerate HBV-induced liver disease. It is known that HBV Pre-S deletion is closely related to HBV-associated terminal liver disease in HBV mono-infection. Currently, data on...
5.
Wu X, Zhao L, Tang S, Weng T, Wu W, Yao S, et al.
Emerg Microbes Infect
. 2020 Apr;
9(1):962-975.
PMID: 32267217
The H7N9 virus mutated in 2017, resulting in new cases of highly pathogenic avian influenza (HPAI) H7N9 virus infection. H7N9 was found in a viraemic patient in Guangdong province, China....
6.
Guo P, Li L, Li W, Zhao J, Hu F, Zhang F, et al.
BMC Infect Dis
. 2019 Nov;
19(1):926.
PMID: 31675923
Background: Myeloid-derived suppressor cells (MDSCs) play immunosuppressive roles in cancers and some infectious diseases; however, their role in dengue fever (DF) remains unknown. This study evaluated the clinical significance of...
7.
Zhao L, Hong W, Wang J, Yu L, Hu F, Qiu S, et al.
J Med Virol
. 2018 Nov;
91(5):872-876.
PMID: 30485459
Understanding of kinetics of antibody responses is crucial for developing rapid serological tests and studying the mechanisms of Zika virus (ZIKV) infection. Most of the serological diagnostic assays previously published...
8.
Wu X, Deng X, Yu D, Yao W, Ou H, Weng T, et al.
Cell Physiol Biochem
. 2018 Apr;
46(2):633-643.
PMID: 29617693
Background/aims: Since the first case of novel H7N9 infection was reported, China has experienced five epidemics of H7N9. During the fifth wave, a highly pathogenic H7N9 strain emerged. In order...
9.
Liu B, Cai W, Hu F, Xu M, Lan Y, Tang X
Zhonghua Gan Zang Bing Za Zhi
. 2013 Dec;
21(11):829-33.
PMID: 24331692
Objective: To investigate the potential differences in response to pegylated interferon (Peg-IFN) plus ribavirin (RBV) combination therapy in patients with hepatitis C virus (HCV) mono-infection and human immunodeficiency virus (HIV)/HCV...
10.
Fan H, Wu L, Hu F, Yang Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
. 2012 Nov;
26(4):282-4.
PMID: 23189845
Objective: To study the gene copy number, mRNA transcription and protien expression of programmed cell death 1 (PD-1) gene in primary hepatocellular carcinoma (PHC) patients and normal control individuals (NC)...